Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors

The Notch signaling ligand JAG1 is overexpressed in various aggressive tumors and is associated with poor clinical prognosis. Hence, therapies targeting oncogenic JAG1 hold great potential for the treatment of certain tumors. Here, we report the identification of specific anti-JAG1 single-chain vari...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Gabriela Silva, Ana F. Rodrigues, Susana Ferreira, Carolina Matos, Rute P. Eleutério, Gonçalo Marques, Khrystyna Kucheryava, Ana R. Lemos, Pedro M. F. Sousa, Rute Castro, Ana Barbas, Daniel Simão, Paula M. Alves
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2023-03-01
Sarja:	Biomolecules
Aiheet:	JAG1 Notch signaling single-chain variable fragment chimeric antigen receptor cytotoxic activity cell therapy
Linkit:	https://www.mdpi.com/2218-273X/13/3/459
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!